Recent

% | $
Quotes you view appear here for quick access.

Cytori Therapeutics, Inc. Message Board

forgotmorthanuno 2521 posts  |  Last Activity: Mar 16, 2015 9:21 PM Member since: Aug 9, 2008
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Forgotmorthanuno

    by rodney.strongg Mar 16, 2015 7:07 PM
    forgotmorthanuno forgotmorthanuno Mar 16, 2015 9:21 PM Flag

    NOBODY knows what the future holds.................true , I never thought we would break the $1.42 , but when we did , I knew what that meant - a count to zero .........from T/A perspective , it is still a count to zero without 2 consecutive daily closes above $1.42....... after 2 closes above our number , we should retest $10 area ..........anyway , it DOES NOT take a brain surgeon to understand basic stuff on t/a ..........$1.42 is your critical number and there is momentum..........when you cant go lower on bad news ( they still have no numbers except bad ones ) you will go higher......that's where u are. It would not surprise me if you never close below $1.20 again........ I'm just guessing that tomorrow is the day that it breaks above resistance.........intraday high of $1.54 would be what I expect ..... I have a few shares that I'm holding out for $80 in the short run..........that's what the count will project with 2 consecutive closes above $10.01........forgotmorthanuno

    Sentiment: Strong Buy

  • Reply to

    Forgot Screwed-up Big Time

    by jamesdean274 Sep 22, 2014 6:55 PM
    forgotmorthanuno forgotmorthanuno Sep 22, 2014 10:08 PM Flag

    I do like the incredible negative sentiment....makes me comfortable. This is like watching a good movie-I'm watching all of it. I've already bought the ticket. As I stated, $1.42 is resistance ..... Must close twice above it to be meaningful. Only gamblers ( me included ) are long. I don't like whiners - probably the thing I hate above all.
    F

    Sentiment: Strong Buy

  • Reply to

    Burn

    by forgotmorthanuno Sep 9, 2014 8:05 AM
    forgotmorthanuno forgotmorthanuno Sep 9, 2014 11:23 AM Flag

    I've bought more shares today and started buying at $1.70 on the way to here. There's no technical ( T/A) reason to buy until it gets above $1.42 and has 2 consecutive daily closes above that. Sometimes you go by the gut feel - I sense that most thnk all hope is lost .......I don't even think that is remotely correct. I think right now is the very best time to buy since I've been trading this dog ......but I love the dog and think things are different than they were a while back. BARDA forced the FDA into a corner ........now the reg path is clear. Just a lil cash and time is all we need .......the time aspect is based on the cash or ability to get cash. A partner deal surely is close ......I would not believe anything else. We are not the only folks who know this stuff works........and there is an abundance of money when the deal is right. I like it.
    F
    ps - I hate it for the people who've lost money on cytx , it should not have turned out the way it did for the past 5 years.

    Sentiment: Strong Buy

  • forgotmorthanuno by forgotmorthanuno Sep 9, 2014 8:05 AM Flag

    With a burn of $6MM/qtr , not a lot of cash is required....... with a few hits on the atm and $4mm , it buys time to make a partner..... I won't insult the intelligence of anybody on this msg brd who has been here a while ( some 10 years ) by stating the obvious virtues of the science , but I do think we are close to deal. It's not so bad here on cytx. Whiners should be buying and not whining ...... trust me , nobody cares whether you are up, down or sideways. It is time to build a big position if you're a risk-taker. If cytx thrives , it will be 10x your imagination as Dean stated ....... If it hits the fan , you lose your money. Simple. Now is not the time to be indecisive.......adding to position.
    F

    Sentiment: Strong Buy

  • forgotmorthanuno forgotmorthanuno Sep 7, 2014 9:42 AM Flag

    There's enough science to do a partner-deal......a good one. However, when the bank ( courtesy Saad ) has their foot on your neck, you're not in a position of strength. If I was Hedrick, I would make a deal with BP that they'd have difficulty refusing. I do think Rickey is the right guy as COB. Let's see if the new CFO has more common sense that Saad. The science is there! Fistula, breast reconstruction, heart,etc..... #$%$?
    I do think the stock will return to $4.05 quickly. Of course, I sold every share at $5.90 a few years ago and started buying from $1.63 to where we are now. I love the science , I believe the science, I know this should be a $100 or $1,000+ stock price ............ IN TIME.
    F

    Sentiment: Strong Buy

  • General Investing
    Cytori Therapeutics Inc. (USA) (CYTX) Developing Promising Stem Cell Device
    August 08, 2014

    WBB Securities Analyst Steve Brozak says one of the biotechnology stocks he is recommending is Cytori Therapeutics Inc. (USA) (CYTX). He says the company’s latest product, which he expects to be marketed in the near future, transcends biotechnology.
    “Cytori’s device extracts stem cells from a patient’s fat, or adipose cells,” Brozak says. “Candidly, it is something where we see this as being the first practical application of stem cells in regenerative medicine that we think will hit the markets in short order.”
    FOR MORE INFORMATION ON THIS INTERVIEW CLICK HERE.
    Brozak says Cytori’s device is used to draw and process a patient’s stem cells, but also includes a biologic process because the cells are used on the same patient to solve a medical issue.
    “They’re testing these cells right now for use in patients that have severe burns. As a matter of fact, Cytori was awarded a BARDA contract to research and develop their technologies in burns and wound healing,” Brozak says. “They’ve been used commercially overseas for breast reconstruction in women who have had breast surgery for oncology purposes. They’ve been used for closing and healing tough-to-treat wounds because these cells obviously lend themselves to adhere and promote healing on open tissue, and we think that’s an exciting area.”
    F

    Sentiment: Strong Buy

  • Reply to

    Brozak forgets CYTX

    by myownhedgefund Sep 4, 2014 9:26 PM
    forgotmorthanuno forgotmorthanuno Sep 5, 2014 1:09 PM Flag

    Brozak is subpar......I used to think he was par.

    Sentiment: Strong Buy

  • Reply to

    Roche spends their money

    by myownhedgefund Aug 24, 2014 2:17 PM
    forgotmorthanuno forgotmorthanuno Aug 24, 2014 5:07 PM Flag

    I knew the rumor amount was "too high" to be cytx..............pays to keep your ear to the ground.

    Sentiment: Strong Buy

  • Reply to

    T/A 101 ........ Bottom should be in

    by forgotmorthanuno Aug 15, 2014 9:39 AM
    forgotmorthanuno forgotmorthanuno Aug 22, 2014 9:08 AM Flag

    Only a complete novice would believe that the Arroyo thing has credibility; that's a headline in the rear view mirror ...... And so yesterday. Just sheared the sheep and caused some to jump ship just at the exact time that they should've been buying aggressively.
    Athena delayed and BARDA is like Goldilock's soup - just right.
    Should be back to $2.60 soon.

    I like it - I love the drama

    Strong buy
    F

    Sentiment: Strong Buy

  • Reply to

    T/A 101 ........ Bottom should be in

    by forgotmorthanuno Aug 15, 2014 9:39 AM
    forgotmorthanuno forgotmorthanuno Aug 21, 2014 3:50 PM Flag

    Buying more CYTX / if we close below support , there's a 20% chance of a spring.
    Strong buy

    Sentiment: Strong Buy

  • Reply to

    T/A 101 ........ Bottom should be in

    by forgotmorthanuno Aug 15, 2014 9:39 AM
    forgotmorthanuno forgotmorthanuno Aug 21, 2014 10:20 AM Flag

    Let's see where it closes .... Should be $1.46 or higher if this is the bottom.

    Sentiment: Strong Buy

  • Reply to

    CYTXW Warrants

    by jamesdean274 Aug 20, 2014 12:40 PM
    forgotmorthanuno forgotmorthanuno Aug 20, 2014 12:43 PM Flag

    Just a short closing out

    Sentiment: Strong Buy

  • forgotmorthanuno by forgotmorthanuno Aug 15, 2014 9:39 AM Flag

    A close below $1.46 would be the stop........Ten times your wildest imagination should be the target.
    .......... and I forgotmorthanuno

    Sentiment: Strong Buy

  • Reply to

    Roche

    by forgotmorthanuno Aug 15, 2014 9:29 AM
    forgotmorthanuno forgotmorthanuno Aug 15, 2014 9:37 AM Flag

    I'm pretty sure any aggressive move by any company to acquire cytori would be met by a n overwhelming response by roche - ey don't want anybody else in their house. Roche would be the only buyer at the end of the day. It's out there being thrown around......smoke and fire scenario
    I predict the bottom was $1.46 / strong buy

    Sentiment: Strong Buy

  • forgotmorthanuno by forgotmorthanuno Aug 15, 2014 9:29 AM Flag

    Blendzyme is the key and is jointly owned ( was co-developed ) by cytori and Roche.
    Nobody would buy cytx except Roche. May be in the cards - time is right.

    Sentiment: Strong Buy

  • forgotmorthanuno forgotmorthanuno Mar 15, 2014 7:24 PM Flag

    This is a major earthquake of an event that nobody (save ATL & forgot......) is paying any attention to. It's very big.

    Sentiment: Strong Buy

  • forgotmorthanuno forgotmorthanuno Mar 6, 2014 6:56 PM Flag

    ATL , my sources are better than most , but you've been right (albeit somewhat early to the party) all along. We're getting ready to rip to your stock price targeted levels. Congrats , the payoff begins.... supply 's been absorbed and getting on top of $6.65 will take it to the house. 2 consecutive daily closes above $6.65 will e the technical level that opens the small floodgates.GLL

    Sentiment: Strong Buy

  • forgotmorthanuno by forgotmorthanuno Dec 4, 2013 4:38 PM Flag

    Acute seizure is where we started, Xanax is a product I think it’s probably still the number one prescribed drug in the world. It’s used for anxiety. It’s used for panic. It’s used for PTST. It’s used for preoperative sedation. It’s used in many areas. As benzodiazepine, it can’t be administered back it is water stable. So what can we do, we can make it work just like an IV for the first time ever. We think in animal models, it shows it’s probably a better drug than some of the benzodiazepines for treating seizure, so there is good methodology mechanistic reasons to try it.

    And we have got a Phase 2 program. We have dosed it a couple of times in patients and so it made sense for us to look at an orphan indication because of two reasons, one it’s more of an expedited pathway but also there is a well established pathway to get it approved because the product has been approved through that...
    Charles Duncan - Piper Jaffray
    In high clinical value.
    Tom King - President, CEO, Director
    Correct and we think it’s speed of onset of these administration with alprazolam AZ-002, is a great way to start. Once you get it approved then you can explore it in Phase 4 studies and other indications, which is a better pathway than going with some big gargantuan opportunity that then would take large clinical trials.
    Charles Duncan - Piper Jaffray
    So when are we going to see data out of that program?
    Tom King - President, CEO, Director
    Probably about a year after we start, so late next year, or early 2015.
    Charles Duncan - Piper Jaffray
    Okay, so you're going to start soon.
    Tom King - President, CEO, Director
    Yes, we're on track to start that in the first quarter next year

    Sentiment: Strong Buy

  • A yeehawwwwwwwwww moment imo........... King said the stock isn't even reflecting adasuve's value , let alone anything else........much Much MUCH higher stock prices very soon. KING " I am confident that we don’t get all the value from ADASUVE into our share price either. But it’s part of the evolution and the transformation, I mean, just basically a year ago we stood here with an inspection of the FDA, we’re not completed a U.S. approval, not completed a SAAG, not completed, I mean, and you turn the clock 12 months to today and all of that work has been done. We have European approval, we have the Teva deal and the products launch. So it has been an incredible 12 to 14 months."........The Parkinson thing was another "vaguely" known item that has received ZERO attention and pleanty of time (perfect timing ) to get it on by 2017 ......... XANAX is the NUMBER 1 PRESCRIBED DRUG IN THE WORLD !............ It's next on ALXA's agenda ....we're going higher.

    Sentiment: Strong Buy

  • forgotmorthanuno by forgotmorthanuno Nov 20, 2013 9:59 AM Flag

    ALXA is front and center with Adasuve - Google " Teva NTE" to read about meeting. Things are proceeding exactly as prescribed. Back above $6 most likely next month.

    Sentiment: Strong Buy

CYTX
2.06+0.01(+0.49%)11:59 AMEDT